Analytica Non-Current Assets
Delisted
The Non-Current Assets of Analytica (ALT.AX) as of Aug 8, 2026 is 148,500.00 AUD. In the previous year, Non-Current Assets was -1.80 M AUD — a change of -108.27% (higher).
Get this data via API
Financial Data API
Non-Current Assets
148,500.00AUD
YoY
-108.27%
Last updated:
Non-Current Assets of Analytica is 2026 148,500.00 AUD. Non-Current Assets of Analytica was 2025 -1.80 M AUD. It decreases by -108.27% higher compared to the previous year.
Access this data via the Eulerpool API
Analytica Stock analysis
What does Analytica do? Analytica Ltd is a British company that was founded in 1970 by Dr. John Smith. Originally, it specialized in the development of analysis instruments for the chemistry and life sciences, particularly liquid chromatography. Over the years, the company expanded its offerings and now provides a wide range of products and services.
Analytica Ltd has become a global company with a presence in over 130 countries. It operates in various business areas, including analytical chemistry, bioanalysis, environmental and food analysis, and clinical diagnostics.
The company offers customers a wide range of products, such as chromatography systems, mass spectrometers, specialized analysis devices, and consumables. It has also specialized in the development and manufacturing of medical devices, including diagnostic tools for conditions such as diabetes, cholesterol, and other metabolic diseases. Analytica Ltd incorporates innovative technologies like miniaturization and nanotechnology into its products.
In addition to product sales, Analytica Ltd provides tailored services. The company has highly qualified experts who assist customers with method development, process optimization, and data interpretation. It also conducts research and development programs to continuously develop new products and technologies.
Analytica Ltd maintains numerous collaborations and partnerships with other companies and organizations. For example, it works closely with research institutions and universities to develop new technologies and products. The company also connects with other companies in the health and analytical industries to share innovations and best practices.
Overall, Analytica Ltd is a leading provider of analysis solutions for the pharmaceutical, biotech, chemical, and food industries, as well as research institutions and clinical laboratories. The company is continuously working to further develop its products and services to meet the needs of its customers and address the ever-changing challenges of the industry. Analytica is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Analytica stock
Non-Current Assets of Analytica is 148,500.00 AUD in 2026.
Non-Current Assets of Analytica changed from -1.80 M AUD to 148,500.00 AUD, representing a -108.27% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Non-Current Assets Analytica since 2006 – with annual values, charts, and detailed analysis.
Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.
Non-Current Assets's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's Analytica historically and in real time.
Access this data via the Eulerpool API
Balance Sheet — Analytica
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — Analytica
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth